Rigel Pharmaceuticals Inc.

09/01/2021 | Press release | Distributed by Public on 09/01/2021 05:32

Data from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients Published in Clinical Infectious Diseases